Lim Domain Binding 2: A Key Driver of Transendothelial Migration of Leukocytes and Atherosclerosis
暂无分享,去创建一个
E. Schadt | J. Björkegren | T. Michoel | O. Melander | A. Hamsten | A. Silveira | U. de Faire | C. Betsholtz | B. Gigante | K. Leander | J. Skogsberg | Ming-Mei Shang | T. Ivert | A. Ruusalepp | C. Niaudet | H. Talukdar | Jennifer J. Hofmann | A. Rossignoli | H. Asl | R. Jain | Cecilia Cedergren
[1] Tom Michoel,et al. kruX: matrix-based non-parametric eQTL discovery , 2013, BMC Bioinformatics.
[2] P. Libby,et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis , 2013, Nature Medicine.
[3] K. Moon,et al. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice. , 2013, Atherosclerosis.
[4] P. Almgren,et al. A myocardial infarction genetic risk score is associated with markers of carotid atherosclerosis , 2012, Journal of internal medicine.
[5] A. Tall,et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. , 2011, The Journal of clinical investigation.
[6] U. de Faire,et al. The Interaction between Coagulation Factor 2 Receptor and Interleukin 6 Haplotypes Increases the Risk of Myocardial Infarction in Men , 2010, PloS one.
[7] V. Bajic,et al. Multi-Organ Expression Profiling Uncovers a Gene Module in Coronary Artery Disease Involving Transendothelial Migration of Leukocytes and LIM Domain Binding 2: The Stockholm Atherosclerosis Gene Expression (STAGE) Study , 2009, PLoS genetics.
[8] H. Westphal,et al. The Ldb1 and Ldb2 transcriptional cofactors interact with the Ste20-like kinase SLK and regulate cell migration. , 2009, Molecular biology of the cell.
[9] E. Major,et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. , 2009, The New England journal of medicine.
[10] P. Libby,et al. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.
[11] L. Sabourin,et al. A novel role for the Ste20 kinase SLK in adhesion signaling and cell migration , 2009, Cell adhesion & migration.
[12] J. Piek,et al. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease. , 2009, Journal of molecular and cellular cardiology.
[13] Regine Heller,et al. Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism , 2008, BMC Medical Genomics.
[14] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[15] A. Zernecke,et al. Neutrophil secretion products pave the way for inflammatory monocytes. , 2008, Blood.
[16] S. Horvath,et al. Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.
[17] J. Tegnér,et al. Transcriptional Profiling Uncovers a Network of Cholesterol-Responsive Atherosclerosis Target Genes , 2008, PLoS genetics.
[18] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[19] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[20] P. Libby,et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.
[21] J. Collins,et al. Large-Scale Mapping and Validation of Escherichia coli Transcriptional Regulation from a Compendium of Expression Profiles , 2007, PLoS biology.
[22] F. Mach,et al. Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches? , 2006, Cellular and Molecular Life Sciences CMLS.
[23] J. Pieters. Faculty Opinions recommendation of Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. , 2006 .
[24] J. Odeberg,et al. Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction , 2005, Journal of internal medicine.
[25] P. Rutgeerts,et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. , 2005, The New England journal of medicine.
[26] M. Beckerle,et al. The LIM domain: from the cytoskeleton to the nucleus , 2004, Nature Reviews Molecular Cell Biology.
[27] William A. Boisvert,et al. Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.
[28] S. Young,et al. Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion , 2003, Circulation.
[29] R. Tibshirani,et al. Empirical bayes methods and false discovery rates for microarrays , 2002, Genetic epidemiology.
[30] M. Cybulsky,et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.
[31] C. Kataoka,et al. New Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Atherosclerosis in Apolipoprotein E-Knockout Mice , 2001, Circulation.
[32] A. Barabasi,et al. Error and attack tolerance of complex networks , 2000, Nature.
[33] L. Jurata,et al. Functional analysis of the nuclear LIM domain interactor NLI , 1997, Molecular and cellular biology.
[34] J. J. Breen,et al. Interactions of the LIM-domain-binding factor Ldbl with LIM homeodomain proteins , 1996, Nature.
[35] S. Grundy. Cholesterol and coronary heart disease. A new era. , 1986, JAMA.
[36] N. Gulbahce,et al. Network medicine: a network-based approach to human disease , 2010, Nature Reviews Genetics.
[37] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[38] C. Turner,et al. JCB Article , 2001 .
[39] A. Fischer. Leukocyte adhesion. , 1993, Clinical and experimental rheumatology.
[40] S M Grundy,et al. Cholesterol and coronary heart disease. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[41] T. Rist,et al. Materials and methods. , 1973, Archives of dermatology.